The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

Abstract Chronic obstructive pulmonary disease (COPD) exacerbations frequently cause patient consultations in both out- and inpatient settings. Recent data suggest that only 40–60% of exacerbations are of bacterial origin and mandate antibiotic treatment. However, a reliable tool to justify prescrib...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcin Paprocki, Szymon Żwirowski, Krzysztof Kuziemski
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-85388-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594785773289472
author Marcin Paprocki
Szymon Żwirowski
Krzysztof Kuziemski
author_facet Marcin Paprocki
Szymon Żwirowski
Krzysztof Kuziemski
author_sort Marcin Paprocki
collection DOAJ
description Abstract Chronic obstructive pulmonary disease (COPD) exacerbations frequently cause patient consultations in both out- and inpatient settings. Recent data suggest that only 40–60% of exacerbations are of bacterial origin and mandate antibiotic treatment. However, a reliable tool to justify prescribing antibiotics for COPD exacerbation is still lacking. This study was designed to explore the hypothesis that utilization of a novel decision-making tool called Prospector would lead to lower consumption of antibiotics and provide a more rational approach to managing COPD exacerbations versus standard therapy in patients with COPD. The study included 77 COPD patients who experienced a COPD exacerbation and were treated in outpatient settings. The Prospector group (PG) (n = 40) were treated by the study author using the Prospector calculator (a tool designed by the first author that translates: patient symptoms, exacerbation, and medical history of COPD into a decision on the use of antibiotics in COPD exacerbation treatment). Other primary care specialists treated the control group (CG) (n = 37) in the same outpatient clinic; antibiotic therapies were implemented at the physician’s discretion, most often using Anthonisen’s criteria. All other medications were administered at the physician’s discretion. Safety endpoints were set as: death, hospitalization, and number of exacerbations. Antibiotics were administered in 32.8% and 81.2% of exacerbations in the PG and CG, respectively (p < 0.0001). A comparable percentage was verified positively in both PG patient subsets: those that did and did not receive antibiotics at visit 1 (94.7% and 94.9%, respectively). Twenty-eight patients in the PG and 37 in the CG were followed for up to 35 months. Failure to recover (defined as deterioration or lack of improvement) in 30 days following exacerbation was 10.7% in the PG and 47.2% in the CG. In the CG, the failure rate was significantly higher (p = 0.0043). Hospitalization rates in the PG and the CG were 42.9% and 94.4%, respectively. In the CG, the hospitalization rate was significantly higher (p < 0.0001). COPD hospitalization rates in the PG and the CG were 17.9% and 33.3%, respectively (p = 0.1643). This preliminary study suggests that using the Prospector calculator results in markedly reduced antibiotic prescription for COPD exacerbations. No new safety signals have been identified for the method.
format Article
id doaj-art-aa2a65d123a34b4da0b8b07b7b494248
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-aa2a65d123a34b4da0b8b07b7b4942482025-01-19T12:20:22ZengNature PortfolioScientific Reports2045-23222025-01-0115111110.1038/s41598-025-85388-2The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseMarcin Paprocki0Szymon Żwirowski1Krzysztof Kuziemski2Private Health Care Facility, Outpatient Clinic SuchaninoAstraZeneca Pharma PolandDivision of Pulmonology, Faculty of Medicine, Medical University of GdańskAbstract Chronic obstructive pulmonary disease (COPD) exacerbations frequently cause patient consultations in both out- and inpatient settings. Recent data suggest that only 40–60% of exacerbations are of bacterial origin and mandate antibiotic treatment. However, a reliable tool to justify prescribing antibiotics for COPD exacerbation is still lacking. This study was designed to explore the hypothesis that utilization of a novel decision-making tool called Prospector would lead to lower consumption of antibiotics and provide a more rational approach to managing COPD exacerbations versus standard therapy in patients with COPD. The study included 77 COPD patients who experienced a COPD exacerbation and were treated in outpatient settings. The Prospector group (PG) (n = 40) were treated by the study author using the Prospector calculator (a tool designed by the first author that translates: patient symptoms, exacerbation, and medical history of COPD into a decision on the use of antibiotics in COPD exacerbation treatment). Other primary care specialists treated the control group (CG) (n = 37) in the same outpatient clinic; antibiotic therapies were implemented at the physician’s discretion, most often using Anthonisen’s criteria. All other medications were administered at the physician’s discretion. Safety endpoints were set as: death, hospitalization, and number of exacerbations. Antibiotics were administered in 32.8% and 81.2% of exacerbations in the PG and CG, respectively (p < 0.0001). A comparable percentage was verified positively in both PG patient subsets: those that did and did not receive antibiotics at visit 1 (94.7% and 94.9%, respectively). Twenty-eight patients in the PG and 37 in the CG were followed for up to 35 months. Failure to recover (defined as deterioration or lack of improvement) in 30 days following exacerbation was 10.7% in the PG and 47.2% in the CG. In the CG, the failure rate was significantly higher (p = 0.0043). Hospitalization rates in the PG and the CG were 42.9% and 94.4%, respectively. In the CG, the hospitalization rate was significantly higher (p < 0.0001). COPD hospitalization rates in the PG and the CG were 17.9% and 33.3%, respectively (p = 0.1643). This preliminary study suggests that using the Prospector calculator results in markedly reduced antibiotic prescription for COPD exacerbations. No new safety signals have been identified for the method.https://doi.org/10.1038/s41598-025-85388-2COPD exacerbationAntibioticsCalculatorC-reactive proteinEosinophil blood countOral glucocorticosteroids
spellingShingle Marcin Paprocki
Szymon Żwirowski
Krzysztof Kuziemski
The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
Scientific Reports
COPD exacerbation
Antibiotics
Calculator
C-reactive protein
Eosinophil blood count
Oral glucocorticosteroids
title The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
title_full The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
title_fullStr The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
title_full_unstemmed The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
title_short The use of the Prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
title_sort use of the prospector calculator reduces antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
topic COPD exacerbation
Antibiotics
Calculator
C-reactive protein
Eosinophil blood count
Oral glucocorticosteroids
url https://doi.org/10.1038/s41598-025-85388-2
work_keys_str_mv AT marcinpaprocki theuseoftheprospectorcalculatorreducesantibiotictherapyinexacerbationsofchronicobstructivepulmonarydisease
AT szymonzwirowski theuseoftheprospectorcalculatorreducesantibiotictherapyinexacerbationsofchronicobstructivepulmonarydisease
AT krzysztofkuziemski theuseoftheprospectorcalculatorreducesantibiotictherapyinexacerbationsofchronicobstructivepulmonarydisease
AT marcinpaprocki useoftheprospectorcalculatorreducesantibiotictherapyinexacerbationsofchronicobstructivepulmonarydisease
AT szymonzwirowski useoftheprospectorcalculatorreducesantibiotictherapyinexacerbationsofchronicobstructivepulmonarydisease
AT krzysztofkuziemski useoftheprospectorcalculatorreducesantibiotictherapyinexacerbationsofchronicobstructivepulmonarydisease